Ankyrin repeat and kinase domain containing protein 1 (ANKK1)

Ankyrin repeat and kinase domain containing protein 1 (ANKK1) is a member of the serine/threonine protein kinase family, with structural domains including an N-terminal kinase domain and C-terminal ankyrin repeats[4][3][1]. These features enable it to phosphorylate substrates and participate in protein–protein interactions within signal transduction pathways. ANKK1 is located adjacent to the dopamine D2 receptor gene (DRD2), and genetic variants in ANKK1 (notably Taq1A) are associated with altered dopamine receptor density and a spectrum of neuropsychiatric and addiction phenotypes[1][3][2][5]. Functionally, ANKK1 is implicated in neurogenesis, neuronal differentiation, cell migration, and regulation of dopaminergic and NF-κB signaling pathways[1][2][3]. The protein exists in multiple isoforms, and is expressed in both central nervous system and muscle precursor cells, where it may contribute to development and cellular signaling[1]. Due to its pivotal role in dopamine-related signaling and disease risk, ANKK1 is a promising molecular target for research in addiction, neuropsychiatric disorders, and personalized medicine[1][3][5].

Other names

Protein kinase PKK2Sugen kinase 288 (SgK288)RIP5X-kinasePKK2sgK288

Modulation of dopamine receptor density and signaling, possibly through kinase activity affecting downstream transcription factors (e.g., NF-κB) or direct alteration of receptor expression Drugs affecting dopaminergic transmission (e.g., apomorphine, D2 agonists) may alter ANKK1 expression/activity